SMTI Sanara MedTech Inc

Price (delayed)

$35.15

Market cap

$322.96M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.7

Enterprise value

$356.07M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 29

Sanara MedTech Inc. is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare ...

Highlights
Sanara MedTech's gross profit has increased by 15% YoY and by 2.3% QoQ
SMTI's quick ratio is up by 15% YoY and by 13% QoQ
SMTI's equity has dropped by 78% year-on-year but it is up by 13% since the previous quarter
Sanara MedTech's debt has increased by 7% YoY

Key stats

What are the main financial stats of SMTI

SMTI stock price

How has the Sanara MedTech stock price performed over time
Intraday
-0.37%
1 week
0.14%
1 month
2.03%
1 year
6.19%
YTD
50.54%
QTD
49%

Financial performance

How have Sanara MedTech's revenue and profit performed over time
Revenue
$109.81M
Gross profit
$102.16M
Operating income
$8.42M
Net income
-$32.01M
Gross margin
93%
Net margin
-29.2%
Sanara MedTech's net margin has shrunk by 186% YoY but it has increased by 6% QoQ
The operating income is up by 33% YoY but it is down by 8% QoQ
The company's operating margin rose by 18% YoY but it fell by 9% QoQ
Sanara MedTech's gross profit has increased by 15% YoY and by 2.3% QoQ

Price vs fundamentals

How does SMTI's price correlate with its fundamentals

Growth

What is Sanara MedTech's growth rate over time

Valuation

What is Sanara MedTech stock price valuation
P/E
N/A
P/B
40.55
P/S
2.77
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.24
SMTI's EPS is up by 4.6% since the previous quarter
SMTI's equity has dropped by 78% year-on-year but it is up by 13% since the previous quarter
The price to book (P/B) is 24% higher than the last 4 quarters average of 32.7
The P/S is 43% lower than the 5-year quarterly average of 4.9 but 39% higher than the last 4 quarters average of 2.0
The company's revenue rose by 13% YoY and by 2.2% QoQ

Efficiency

How efficient is Sanara MedTech business performance
The company's return on equity has shrunk by 92% QoQ
SMTI's return on sales is up by 8% since the previous quarter
Sanara MedTech's return on invested capital has increased by 6% QoQ
The company's return on assets fell by 5% QoQ

Dividends

What is SMTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SMTI.

Financial health

How did Sanara MedTech financials performed over time
The company's total assets is 13% higher than its total liabilities
The company's total assets fell by 30% YoY
SMTI's quick ratio is up by 15% YoY and by 13% QoQ
SMTI's equity has dropped by 78% year-on-year but it is up by 13% since the previous quarter
SMTI's debt to equity is down by 11% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.